Sage Therapeutics, Inc. (SAGE)
NASDAQ: SAGE · Real-Time Price · USD
4.920
+0.010 (0.20%)
Nov 21, 2024, 1:39 PM EST - Market open
Sage Therapeutics Employees
Sage Therapeutics had 487 employees as of December 31, 2023. The number of employees decreased by 202 or -29.32% compared to the previous year.
Employees
487
Change (1Y)
-202
Growth (1Y)
-29.32%
Revenue / Employee
$218,478
Profits / Employee
-$693,211
Market Cap
300.97M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
OraSure Technologies | 638 |
Cerus | 637 |
uniQure | 480 |
C4 Therapeutics | 145 |
Kodiak Sciences | 111 |
ClearPoint Neuro | 107 |
Atai Life Sciences | 83 |
Design Therapeutics | 58 |
SAGE News
- 1 day ago - After Failed Alzheimer's Study, Sage Therapeutics' Dalzanemdor Flunks Another Study In Patients With Inherited Brain Disorder - Benzinga
- 1 day ago - Sage Therapeutics to end Huntington's disease trial after key therapy fails again - Market Watch
- 1 day ago - Sage Therapeutics scraps development of rare disease drug after it fails mid-stage study - Reuters
- 1 day ago - Sage Therapeutics Announces Topline Results from the Phase 2 DIMENSION Study of Dalzanemdor (SAGE-718) in the Treatment of Cognitive Impairment Associated with Huntington's Disease - Business Wire
- 22 days ago - Sage Therapeutics, Inc. (SAGE) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Sage Therapeutics Announces Third Quarter 2024 Financial Results and Highlights Pipeline and Business Updates - Business Wire
- 24 days ago - Sage Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SAGE - PRNewsWire
- 25 days ago - DEADLINE TOMORROW: Sage Therapeutics, Inc. Is Being Sued For Violating Securities Laws And Affected Shareholders Are Urged To Contact The Schall Law Firm - Accesswire